Хлебные крошки
- Главная
-
Аналитика
-
Акции
Акции внутренные
Comera Life Sciences Holdings, Inc. CMRA
$0.60
-$0.08 (-14.07%)
На 18:06, 12 мая 2023
Ранг: 3
Ключевые показатели
-
Marketcap
17159697.00000000
-
week52high
15.30
-
week52low
0.63
-
Revenue
633102
-
P/E TTM
0
-
Beta
0.95619800
-
EPS
-1.76000000
-
Last Dividend
0.00000000
-
Next Earnings Date
15 июн 2023 г. в 04:00
Описание компании
Comera Life Sciences Holdings, Inc., a preclinical stage life sciences company, develops an internal portfolio of proprietary therapeutics that incorporate its proprietary formulation platform, SQore. Its SQore platform is designed to enable the conversion of intravenous (IV) biologics to subcutaneous (SQ) versions. The company is advancing its primary product programs, CLS-001, a preclinical stage biobetter for Crohn's and Ulcerative Colitis disease, and CLS-002, a preclinical stage biobetter for various oncology indications. Comera Life Sciences Holdings, Inc. was founded in 2014 and is headquartered in Woburn, Massachusetts.
Свежие комментарии
Свежие комментарии
Оставьте свой голос
Оставьте свой голос
Анонимное голосование
Будет ли рост российского рынка к концу года?
-
Да
87% -
Нет
12%
Проголосовал 8 человек
Новостная лента
компании
Insider Summary
Insider Summary
| Reporting Name | Acquistion/Disposition | Owned | Transacted | Transaction Date |
|---|---|---|---|---|
| Cherington Charles | A | 743243 | 743243 | 04 янв 2023 г. |
| Cherington Charles | A | 2879666 | 743243 | 04 янв 2023 г. |
| FLOWERS KIRSTEN | A | 13513 | 13513 | 04 янв 2023 г. |
| FLOWERS KIRSTEN | A | 22199 | 13513 | 04 янв 2023 г. |
| Sullivan Edward Aloysius Jr. | A | 10979 | 10979 | 04 янв 2023 г. |
| Sullivan Edward Aloysius Jr. | A | 19665 | 10979 | 04 янв 2023 г. |
| RANDLE STUART A | A | 33783 | 33783 | 04 янв 2023 г. |
| RANDLE STUART A | A | 42469 | 33783 | 04 янв 2023 г. |
| Sherblom James | A | 81081 | 81081 | 04 янв 2023 г. |
| Sherblom James | A | 452244 | 81081 | 04 янв 2023 г. |
Новостная лента
Comera Life Sciences to Present at 22nd Annual PepTalk Conference
GlobeNewsWire
12 янв 2023 г. в 16:15
WOBURN, Mass., Jan. 12, 2023 (GLOBE NEWSWIRE) -- Comera Life Sciences Holdings, Inc. (Nasdaq: CMRA) (“Company” or “Comera”), a life sciences company developing a new generation of bio-innovative biologic medicines to improve patient access, safety and convenience, today announced it will present at the 22nd Annual PepTalk Conference, in San Diego on Wednesday, Jan. 18, 2023 at 5:15 p.m. PT. The conference will run from Monday, Jan. 16 through Friday, Jan. 20.
Comera Life Sciences to Participate in the Benchmark Company's Upcoming Discovery One-on-One Investor Conference
GlobeNewsWire
17 ноя 2022 г. в 16:05
WOBURN, Mass., Nov. 17, 2022 (GLOBE NEWSWIRE) -- Comera Life Sciences Holdings, Inc. (Nasdaq: CMRA), a life sciences company developing a new generation of bio-innovative biologic medicines to improve patient access, safety, and convenience, today announced it will be participating in the Benchmark Company's 11th Annual Discovery One-on-One Investor Conference to be held Thursday, December 1, 2022 at the New York Athletic Club in New York.
3 Hot Penny Stocks To Buy According To Insiders In September
PennyStocks
15 сент 2022 г. в 13:52
Penny stocks to buy? That's what these insiders think.
Top Penny Stocks to Watch After the Market Crash
PennyStocks
14 сент 2022 г. в 06:00
Here's what you need to know about buying penny stocks today The post Top Penny Stocks to Watch After the Market Crash appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
Insiders Are Buying Up Comera Life Sciences (CMRA) Stock. Here's Why.
InvestorPlace
13 сент 2022 г. в 14:33
Shares of Comera Life Sciences (NASDAQ: CMRA ) are up by over 30% following a flurry of insider purchases. As the name suggests, Comera is a life sciences company that seeks to improve traditional intravenous injections through its SQore platform.